(Q36345210)

English

Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

0 references

Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis (English)

1 reference

Europe PubMed Central

13 August 2017

hepatorenal syndrome

1 reference

based on heuristic

inferred from title

author name string

Antonio Facciorusso

1

1 reference

Europe PubMed Central

13 August 2017

Apoorva K Chandar

2

1 reference

Europe PubMed Central

13 August 2017

M Hassan Murad

3

1 reference

Europe PubMed Central

13 August 2017

Larry J Prokop

4

1 reference

Europe PubMed Central

13 August 2017

Nicola Muscatiello

5

1 reference

Europe PubMed Central

13 August 2017

Patrick S Kamath

6

1 reference

Europe PubMed Central

13 August 2017

Siddharth Singh

7

1 reference

Europe PubMed Central

13 August 2017

publication date

2 December 2016

1 reference

Europe PubMed Central

13 August 2017

The lancet. Gastroenterology & hepatology

1 reference

Europe PubMed Central

13 August 2017

2

1 reference

Europe PubMed Central

13 August 2017

2

1 reference

Europe PubMed Central

13 August 2017

94-102

1 reference

Europe PubMed Central

13 August 2017

Renal failure in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Conceptual and Technical Challenges in Network Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

GRADE guidelines 6. Rating the quality of evidence—imprecision

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930157-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(16)30157-1

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36345210&oldid=1627370555"